Svetlana Madjunkova

Svetlana Madjunkova

Auto-generated profile, based on publicly available information

Svetlana Madjunkova

CReATe Fertility Centre, Toronto, Canada

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
10 May 2018 in PLOS ONE
Verified
Journal Article
Open access
PDF file
VKValeriy Kuznyetsov
Valeriy Kuznyetsov
SMSvetlana Madjunkova
Svetlana Madjunkova
RARan Antes
Ran Antes
RARina Abramov
Rina Abramov
GMGelareh Motamedi
Gelareh Motamedi
CLClifford Librach
Clifford Librach
To assess whether embryonic DNA isolated from blastocyst culture conditioned medium (BCCM) combined with blastocoel fluid (BF) could be used for blastocyst stage non-invasive preimplantation genetic testing for chromosomal aneuploidy (non-invasive preimplantation genetic screening, NIPGS). 47 embryos from 35 patients undergoing IVF. DNA analysis of combined BCCM plus BF in comparison with trophectoderm (TE) biopsy and/or whole blastocyst (WB)using next generation sequencing (NGS). Embryonic DNA was successfully amplified in 47/47 NIPGS samples (28 frozen-thawed and 19 fresh culture samples) ranging from 6.3 to 44.0 ng/μl. For frozen-thawed embryos, the concordance rate for whole chromosome copy number per sample was equivalent between NIPGS vs. TE biopsy, NIPGS vs. WB and TE vs. WB samples taken from the same embryo was 87.5%; 96.4% and 91.7% respectively (P>0.05), and the rate of concordance per single chromosome was 99.3%, 99.7% and 99.7%, respectively (P>0.05). In fresh cases (Day 4 to Day 5/6 culture), the concordance rate for whole chromosome copy number per sample between NIPGS vs. TE samples taken from the same embryo was 100%, and the rate of concordance per single chromosome was 98.2% (P>0.05). A combination of BCCM and BF contains sufficient embryonic DNA for whole genome amplification and accurate aneuploidy screening. Our findings suggest that aneuploidy screening using BCCM combined with BF could potentially serve as a novel NIPGS approach for use in human IVF.

8 January 2016 in PLOS ONE
Verified
Journal Article
Open access
PDF file
PNPredrag Noveski
Predrag Noveski
SMSvetlana Madjunkova
Svetlana Madjunkova
ESEmilija Sukarova Stefanovska
Emilija Sukarova Stefanovska
NGNadica Matevska Geshkovska
Nadica Matevska Geshkovska
MKMaja Kuzmanovska
Maja Kuzmanovska
DPDijana Plaseska-Karanfilska
Dijana Plaseska-Karanfilska
Although age-related loss of chromosome Y (LOY) in normal hematopoietic cells is a well-known phenomenon, the phenotypic consequences of LOY have been elusive. However, LOY has been found in association with smoking, shorter survival and higher risk of cancer. It was suggested that LOY in blood cells could become a predictive biomarker of male carcinogenesis. To investigate the association of LOY in blood cells with the risk for development of colorectal (CC) and prostate cancers (PC), we have analyzed DNA samples from peripheral blood of 101 CC male patients (mean age 60.5±11.9 yrs), 70 PC patients (mean age 68.8±8.0 yrs) and 93 healthy control males (mean age 65.8±16.6 yrs). The methodology included co-amplification of homologous sequences on chromosome Y and other chromosomes using multiplex quantitative fluorescent (QF) PCR followed by automatic detection and analysis on ABI 3500 Genetic Analyzer. The mean Y/X ratio was significantly lower in the whole group of cancer patients (0.907±0.12; p = 1.17x10-9) in comparison to the controls (1.015±0.15), as well as in CC (0.884±0.15; p = 3.76x10-9) and PC patients (0.941±0.06; p = 0.00012), when analyzed separately. Multivariate logistic regression analysis adjusting for LOY and age showed that LOY is a more significant predictor of cancer presence than age, and that age probably does not contribute to the increased number of subjects with detectable LOY in cancer patients cohort. In conclusion, our results support the recent findings of association of LOY in blood cells with carcinogenesis in males.

1 August 2014 in Reproductive Toxicology
Verified
Journal Article
Closed access
GKGideon Koren
Gideon Koren
SMSvetlana Madjunkova
Svetlana Madjunkova
CMCaroline Maltepe
Caroline Maltepe

29 April 2020 in Scientific Reports
Verified
Journal Article
Open access
PDF file
VKValeriy Kuznyetsov
Valeriy Kuznyetsov
SMSvetlana Madjunkova
Svetlana Madjunkova
RARina Abramov
Rina Abramov
RARan Antes
Ran Antes
ZIZenon Ibarrientos
Zenon Ibarrientos
CLClifford L. Librach
Clifford L. Librach
Preimplantation genetic testing for aneuploidies (PGT-A) using trophectoderm (TE) biopsy samples is labour intensive, invasive, and subject to sampling bias. In this study, we report on the efficacy and factors affecting accuracy of a technique we pioneered for minimally invasive preimplantation genetic testing for aneuploidy (miPGT-A). Our technique uses cell-free embryonic DNA (cfeDNA) in spent embryo culture medium (SEM) combined with blastocoel fluid (BF) to increase the amount of assayable cfeDNA. We compared miPGT-A results (n = 145 embryos) with standard PGT-A analysis of the corresponding trophectoderm biopsy. We found that accuracy of miPGT was not related to blastocyst morphological grade. The overall concordance rate per sample for euploidy/aneuploidy status between miPGT-A and TE biopsy samples was 88/90 (97.8%), and was not different between good 47/48 (97.9%) and moderate/low quality blastocysts 41/42 (97.9%) (p > 0.05). Importantly, we also discovered that for cfeDNA analysis, the SurePlex whole genome amplification (WGA) kit can be utilized without an additional cell lysis/extraction DNA step; this efficiency likely reduces the risk of maternal contamination. Regarding origin of embryonic cfeDNA, the average amount of miPGT-A WGA-DNA we obtained from blastocysts with different morphological grades, as well as the size miPGT-A WGA-DNA fragments, suggest that it is unlikely that apoptosis and necrosis are only mechanisms of DNA release from the inner cell mass (ICM) and TE into BF and SEM.

1 August 2020 in Fertility and Sterility
Verified
Journal Article
Closed access
MDMichal Dviri
Michal Dviri
SMSvetlana Madjunkova
Svetlana Madjunkova
AKAlex Koziarz
Alex Koziarz
RARan Antes
Ran Antes
RARina Abramov
Rina Abramov
CLClifford Librach
Clifford Librach

1 December 2012 in Balkan Journal of Medical Genetics
Verified
Journal Article
Open access
PDF file
DPDijana Plaseska-Karanfilska
Dijana Plaseska-Karanfilska
PNP Noveski
P Noveski
TPT Plaseski
T Plaseski
IMI Maleva
I Maleva
SMS Madjunkova
S Madjunkova
ZMZ Moneva
Z Moneva